Contraceptive Drugs Market Size, Share and Industry Analysis By Product Type (Oral, Injectable & Patches), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel & NGOs), and Regional Forecast 2020-2029 (Includes COVID-19 Business Impact)

                                          
We have updated Contraceptive Drugs Market with respect to COVID-19 Business Impact.
Inquire before buying


This report focuses on the Contraceptive Drugs market and value at the global level, regional level, and company level. From a global perspective, this report represents the overall Contraceptive Drugs market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America.


Global Contraceptive Drugs Market: Segment Analysis


The research report includes specific segments by region (country), by Company, by Type, and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2019 to 2029. An in-depth analysis of the segments assists in identifying the different factors that will aid market growth.


Global Contraceptive Drugs Market: Regional Analysis


The research report includes a detailed study of regions of North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America. The report has been curated after observing and studying various factors that determine regional growth such as the economic, environmental, social, technological, and political status of the particular region. Researchers have studied the data of revenue, sales, and manufacturers of each mentioned region. This section analyses region-wise revenue and volume for the forecast period of 2019 to 2029.


Global Contraceptive Drugs Market: Competitive Landscape


This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2019 to 2029.
List of Companies Profiled

  
Bayer AG
  
Pfizer Inc.
  
Janssen Global Services, LLC
  
Teva Pharmaceutical Industries Ltd.
  
Merck & Co., Inc.
  
Mylan N.V.
  
Allergan Plc
  
Agile Therapeutics
  
Piramal Enterprises Ltd.

Report Coverage

Contraceptive drugs are medications used for the prevention of unwanted pregnancy. Contraceptive drugs are available in the form of oral pills, injections, and patches and have established their dominance as a means of emergency contraception. Use of contraceptive drugs can reduce the risk on womens health due to early childbearing, unsafe abortion, and infant mortality rate.

The report provides qualitative and quantitative insights on the contraceptive drugs industry trends and detailed analysis of market size & growth rate for all possible segments in the market. The market is segmented by product type and distribution channel. On the basis of product type, the global contraceptive drugs market is categorized into oral (combined contraceptives and progestin-only pills), injectable, and patches. Various distribution channels for contraceptive drugs include hospital pharmacy, retail pharmacy, clinics, online channel, public channels & NGOs, and others. Geographically, the market is segmented into five major regions, which are North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions are further categorized into countries.

Along with this, the report analysis includes market dynamics and competitive landscape. Various key insights provided in the report are fertility statistics for key countries, new product launch, pipeline analysis, recent industry developments such as partnerships, mergers and acquisitions, and regulatory scenarios for key countries.

SEGMENTATION

By Product Type 

  
Oral
  
Combined Contraceptives
  
Progestin-only Pills
  
Injectable
  
Patches

By Distribution Channel

  
Hospital Pharmacy
  
Retail Pharmacy
  
Clinics
  
Online Channel
  
Public Channel & NGOs
  
Others

By Geography

  
North America (USA and Canada)
  
Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  
Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  
Latin America (Brazil, Mexico and Rest of Latin America)
  
Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)

Key Industry Development

In November 2018, The Population Council, Los Angeles Biomedical Research Institute, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and University of Washington School of Medicine launched first clinical study to test the efficacy and safety of a gel to be used by men for the prevention of unintended pregnancy

In August 2018, Lupin Pharmaceuticals announced the launch of Drospirenone, Ethinyl Estradiol, and Levomefolate Calcium tablets contraceptive drugs in the U.S.

In May 2018, Aurobindo Pharma launched MILI and TRI-MILI oral contraceptive tablets for use in women to avoid conception.

In April 2018, Mylan N.V., launched generic YAZ oral contraceptive drug for use by women to avoid unintential pregnancy.